Wegovy vs Mounjaro: Which Weight Management Option Suits You?
Is Wegovy The Same As Ozempic? Understanding Semaglutide vs Tirzepatide
The question "is Wegovy the same as Ozempic" highlights important licensing distinctions that affect UK patients. Wegovy and Ozempic contain identical semaglutide, but Ozempic is exclusively licensed for type 2 diabetes treatment – prescribing it for weight loss constitutes off-label use. Wegovy represents the only MHRA-approved semaglutide treatment for weight management, specifically licensed for adults with BMI ≥30 or BMI ≥27 with weight-related comorbidities. Understanding whether Wegovy is the same as Ozempic helps patients choose appropriate, legally compliant treatment options.
Mounjaro (tirzepatide) offers a fundamentally different mechanism compared to Wegovy's semaglutide. Whilst both are prescription-only medicines requiring clinical assessment, Mounjaro targets both GIP and GLP-1 receptors as a dual agonist, compared to Wegovy's GLP-1-only approach. When patients ask "is Wegovy the same as Ozempic" whilst considering Mounjaro, they're comparing single-hormone semaglutide against dual-hormone tirzepatide. Both Wegovy and Mounjaro are available from EverydayMeds, allowing your prescriber to determine which mechanism suits your individual circumstances.
Wegovy vs Mounjaro Pricing: Transparent Cost Comparison
EverydayMeds offers competitive pricing for both treatments, with Wegovy starter doses beginning at £79.99 (0.25mg) and Mounjaro starting at £149.99 (2.5mg). Our Wegovy dose escalation follows 0.25mg → 0.5mg (£94.99) → 1mg (£99.99) → 1.7mg (£139.99) → 2.4mg maintenance (£209.99). New customers receive code FIRST40 whilst returning customers use DOSE25, both applied at checkout to reach these final prices. Understanding "is Wegovy the same as Ozempic" becomes irrelevant when considering legal, licensed alternatives with transparent pricing.
Bundle options provide convenience for continuous treatment, with our Intro Trio (Wegovy 0.25mg, 0.5mg, 1mg) priced at £299.99 for three months' dose escalation. Mounjaro follows its own escalation schedule with different dosing intervals. Rather than asking "is Wegovy the same as Ozempic," patients benefit from comparing these two licensed weight management options available through one pharmacy. Both treatments require ongoing commitment, making bundle convenience valuable for maintaining consistent treatment schedules.
Clinical Evidence: STEP Trials vs SURMOUNT Studies
Clinical evidence distinguishes why asking "is Wegovy the same as Ozempic" misses crucial licensing differences for weight management. Wegovy's STEP trials demonstrated significant results, with STEP 1 showing ~15% average weight loss at 68 weeks versus ~2.4% placebo, as published by Wilding et al. in NEJM, 2021. These studies specifically investigated semaglutide for weight management in appropriate patient populations. The STEP programme validates Wegovy's licensed indication for weight management when used alongside reduced-calorie diet and increased physical activity.
Mounjaro's SURMOUNT trials investigated tirzepatide's dual-hormone mechanism for weight management, though direct comparison between STEP and SURMOUNT results isn't appropriate due to different trial designs and patient populations. Both studies support their respective treatments' efficacy when prescribed appropriately. Rather than questioning whether Wegovy is the same as Ozempic, patients benefit from understanding that both Wegovy and Mounjaro represent evidence-based, licensed approaches to weight management available through EverydayMeds.
How Wegovy Works: GLP-1 Receptor Mechanism Explained
Wegovy functions as a GLP-1 receptor agonist, mimicking natural fullness hormones that regulate appetite and satiety. This mechanism reduces appetite by acting on brain appetite centres, promoting feelings of fullness after smaller meals whilst potentially reducing food cravings. The once-weekly injection maintains consistent hormone levels throughout the week, supporting sustainable appetite management. Wegovy's FlexTouch pen delivery system ensures accurate dosing during the mandatory dose escalation schedule. Understanding this mechanism clarifies why questions about "is Wegovy the same as Ozempic" focus on licensing rather than pharmacological differences, as both contain identical semaglutide.
EverydayMeds Ordering Process: From Assessment To Delivery
Our streamlined process begins with a 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Qualified prescribers review applications within 3 working days (express 24-hour service available), determining treatment suitability for either Wegovy or Mounjaro based on individual circumstances. Once approved, next-day delivery ensures rapid treatment commencement using cold-chain, temperature-controlled packaging. Our GPhC-registered pharmacy (#9012878) maintains strict standards for prescription-only medicine dispensing. Rather than wondering "is Wegovy the same as Ozempic," patients can access appropriate, licensed treatments through one comprehensive service supporting both Wegovy and Mounjaro prescribing.
Storage and Practical Considerations: Wegovy vs Mounjaro
Storage requirements differ between treatments, providing practical considerations beyond asking "is Wegovy the same as Ozempic." Wegovy maintains potency for 6 weeks at room temperature (below 30°C) once removed from fridge storage (2-8°C), compared to Mounjaro's 21-day room temperature limit. This storage advantage makes Wegovy more convenient for travel or lifestyle flexibility. Both treatments use pre-filled pen systems with different dose escalation schedules – Wegovy's 5-dose escalation versus Mounjaro's 6-dose progression. Dose escalation cannot be skipped for either treatment, requiring patient commitment to gradual titration schedules designed to minimise side effects whilst maximising efficacy.
Dual-Hormone vs Single-Hormone Approach: Mounjaro vs Wegovy Mechanisms
The fundamental difference between these treatments lies in their hormonal targets rather than whether Wegovy is the same as Ozempic. Mounjaro's tirzepatide simultaneously activates GIP and GLP-1 receptors, creating a dual-hormone approach to appetite regulation and glucose metabolism. This dual mechanism potentially offers different benefits compared to Wegovy's GLP-1-only approach, though individual responses vary significantly. Both treatments require prescription alongside lifestyle modifications including reduced-calorie diet and increased physical activity.
Prescriber expertise becomes crucial when selecting between single-hormone and dual-hormone approaches based on patient-specific factors including medical history, concurrent medications, and treatment goals. EverydayMeds prescribers can assess suitability for either mechanism, avoiding the need to question whether Wegovy is the same as Ozempic by focusing on appropriate, licensed alternatives. Both treatments represent significant advances in weight management pharmacotherapy when prescribed appropriately to suitable candidates.
Start Your Weight Management Journey: Licensed Treatment Options Available
EverydayMeds provides access to both Wegovy and Mounjaro through our comprehensive prescription service, eliminating confusion about "is Wegovy the same as Ozempic" by focusing on appropriate, licensed treatments. Begin with our 3-minute clinical assessment, using discount codes FIRST40 (new customers) or DOSE25 (returning customers) applied at checkout. Our qualified prescribers determine treatment suitability based on individual circumstances, medical history, and weight management goals. Both treatments require ongoing commitment alongside lifestyle modifications, with our pharmacy providing continuous support throughout your journey. Visit https://everydaymeds.co.uk/collections/weight-loss to compare options and begin your clinical assessment today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
